Provided by Tiger Fintech (Singapore) Pte. Ltd.

Redhill Biopharma

2.86
-0.1500-4.98%
Post-market: 2.63-0.2300-8.04%19:49 EDT
Volume:1.18M
Turnover:3.64M
Market Cap:3.66M
PE:-0.07
High:2.88
Open:2.85
Low:2.60
Close:3.01
Loading ...
Mar 07, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 27, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 11, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Aug 05, 2021

Correspondence

CORRESP [Cover] - Correspondence
May 27, 2021

important event

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
May 03, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Apr 06, 2021

Correspondence

CORRESP [Cover] - Correspondence
Mar 25, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 18, 2021

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Mar 18, 2021

important event

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Mar 02, 2021

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Mar 01, 2021

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Mar 01, 2021

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Jan 15, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 12, 2021

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Jan 11, 2021

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses